1. Home
  2. AFCG vs ADAP Comparison

AFCG vs ADAP Comparison

Compare AFCG & ADAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AFCG
  • ADAP
  • Stock Information
  • Founded
  • AFCG 2020
  • ADAP 2008
  • Country
  • AFCG United States
  • ADAP United Kingdom
  • Employees
  • AFCG N/A
  • ADAP N/A
  • Industry
  • AFCG Real Estate Investment Trusts
  • ADAP Biotechnology: Pharmaceutical Preparations
  • Sector
  • AFCG Real Estate
  • ADAP Health Care
  • Exchange
  • AFCG Nasdaq
  • ADAP Nasdaq
  • Market Cap
  • AFCG 196.7M
  • ADAP 158.6M
  • IPO Year
  • AFCG 2021
  • ADAP 2015
  • Fundamental
  • Price
  • AFCG $8.62
  • ADAP $0.58
  • Analyst Decision
  • AFCG Buy
  • ADAP Strong Buy
  • Analyst Count
  • AFCG 6
  • ADAP 4
  • Target Price
  • AFCG $12.00
  • ADAP $2.79
  • AVG Volume (30 Days)
  • AFCG 219.0K
  • ADAP 2.3M
  • Earning Date
  • AFCG 03-06-2025
  • ADAP 03-05-2025
  • Dividend Yield
  • AFCG 15.28%
  • ADAP N/A
  • EPS Growth
  • AFCG N/A
  • ADAP N/A
  • EPS
  • AFCG 0.40
  • ADAP N/A
  • Revenue
  • AFCG $43,164,939.00
  • ADAP $175,041,000.00
  • Revenue This Year
  • AFCG N/A
  • ADAP $204.91
  • Revenue Next Year
  • AFCG N/A
  • ADAP N/A
  • P/E Ratio
  • AFCG $33.60
  • ADAP N/A
  • Revenue Growth
  • AFCG N/A
  • ADAP 146.27
  • 52 Week Low
  • AFCG $7.45
  • ADAP $0.53
  • 52 Week High
  • AFCG $10.88
  • ADAP $2.05
  • Technical
  • Relative Strength Index (RSI)
  • AFCG 46.33
  • ADAP 41.87
  • Support Level
  • AFCG $8.22
  • ADAP $0.55
  • Resistance Level
  • AFCG $8.49
  • ADAP $0.65
  • Average True Range (ATR)
  • AFCG 0.24
  • ADAP 0.05
  • MACD
  • AFCG 0.04
  • ADAP 0.00
  • Stochastic Oscillator
  • AFCG 67.50
  • ADAP 31.31

About AFCG AFC Gamma Inc.

Advanced Flower Capital Inc is a commercial mortgage REIT that provides institutional loans to state-law-compliant cannabis operators in the U.S. Through the management team's deep network and significant credit and cannabis expertise, AFC originates, structures and underwrites loans ranging from $10 million to over $100 million, typically secured by quality real estate assets, license value and cash flows.

About ADAP Adaptimmune Therapeutics plc

Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70 and others for multiple cancer types.

Share on Social Networks: